Healthcare -
Biotechnology - NASDAQ - US
$ 0.8696
-0.046 %
$ 47.4 M
Market Cap
10.87
P/E
SPRO - GROSS PROFIT
Gross Profit SPRO - Spero Therapeutics, Inc.
96.4 M
LAST VALUE
137.12%
2 YEAR CAGR
39.17%
5 YEAR CAGR
0.00%
10 YEAR CAGR